.Merck defeats profits requirements, rears purchases expectation on solid need for top medications like Keytruda CNBCMerck & Co. (MRK US) Defeats Profit Estimates as Keytruda Purchases Increase BloombergMerck Inventory: Pharma Titan Posts Powerful End Results, Yet Outlook Tumbles Short Investor's Organization DailyMerck Announces Second-Quarter 2024 Financial Outcomes Yahoo FinanceMerck defeats revenue and sales assumptions among Keytruda strong point, however gives mixed full-year expectation MarketWatch.